AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Differentiating Ketamine and MDMA, Addiction, and Potential Applications
Psilocybin has a longer therapeutic response compared to ketamine. Ibogaine's clinical research is hindered by cardio toxicity concerns. Ketamine and MDMA are not true hallucinogens and have different addictive and physiological properties. More research is needed to determine the addictive nature of MDMA. Ketamine is effective for acute suicidality. It provides fast-acting relief from depression.